Invitrogen Expands High-Throughput Assays With Molecular Probes Purchase
This article was originally published in The Gray Sheet
Executive Summary
Invitrogen will enhance its high-throughput, drug discovery screening assays with Molecular Probes, Inc.'s fluorescent molecular labeling detection systems under a $325 mil. proposed acquisition
You may also be interested in...
Fisher Casts For Proteomics Consumables; Perbio Deal Offers Device Angle
Fisher Scientific will explore the viability of Perbio Science AB's medical device unit within a planned merger of the two companies, announced June 26
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.